Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The new coronavirus crisis has upended the clinical trials process around the world.
New forms of treatment and PrEP and, hopefully, an at least partially effective vaccine will be key to fighting the epidemic in the 2020s.
Calling all U.S. cisgender gay and bi men and trans and gender nonconforming people at risk for the virus.
The ASCENT trial found that the vaccine regimen that was advanced to the forthcoming Mosaico trial prompted a strong immune response.
The vaccine in the APPROACH study, which led to the Imbokodo and forthcoming Mosaico trails, prompted a robust immune response.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.